Rapid Evacuation and Access of Cerebral Hemorrhage Registry
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT07651631
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Intracerebral Hemorrhage
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2033
- Completion
- Jun 30, 2033
Study Design
- Enrollment
- 2,500 participants (estimated)
Arms
- Arm: Minimally Invasive Surgical Groups* Surgical A: Endport evacuation (i.e., MIPS via BrainPath or similar device) * Surgical B: Endoscopic evacuation * Surgical C: Catheter-based evacuation * Surgical D: Other minimally invasive surgical techniques involving clot evacuation
- Arm: Control GroupNo minimally invasive surgical hematoma evacuation performed; n=300 total, capped across 20 sites; may include patients undergoing decompressive hemicraniectomy or other standard medical/surgical approaches): * Basal Ganglia Controls (\>50% IVH or ICH volume ≥80 mL; n=100) * Lobar Controls (ICH volume ≥80 mL; n=100) * Primary Thalamic Controls (n=100) * ENRICH Trial Controls (ABG and lobar locations; n=150) * REACH Trial Controls (ABG location; n=maximum 300)
Primary Outcome Measure
Modified Rankin Scale (mRS) at 180 Days [ Time Frame: Day 180 from baseline (±14 days) ]
Central Contacts
- Alex Hall, DHSc404-778-1585
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | Alex Hall, DHSc, MS Alex Hall, DHSc, MS (PRINCIPAL_INVESTIGATOR) Jonathan Ratcliff, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
By research site
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Clevidipine for the Antihypertensive Treatment of Acute Intracerebral HemorrhageRecruiting · Zeenat Qureshi Stroke Institute · Irvine, California
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2PHASE3 · Recruiting · Joseph Broderick, MD · Birmingham, Alabama
- Statins In Intracerbral HemorrhagePHASE3 · Recruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts